RONAK R SHAH
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology PLANTATION, FL NPI 1679069538
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology FL Merck Sharp & Dohme Corporation All categories
General Payments — all program years on this page
$4,117.94
- Category: General Payments
- Program years: PY2018–2024
- Record count: 164
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,644.15 across 66 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,266.70 | 62 |
| Education | $377.45 | 4 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Merck Sharp & Dohme Corporation | $242.57 | 12 |
| SOBI, INC | $207.11 | 4 |
| Lilly USA, LLC | $181.18 | 6 |
| Daiichi Sankyo Inc. | $138.34 | 7 |
| Incyte Corporation | $126.31 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $115.69 | 6 |
| Celgene Corporation | $109.59 | 5 |
| Regeneron Healthcare Solutions, Inc. | $106.45 | 4 |
| EISAI INC. | $80.08 | 4 |
| Genentech USA, Inc. | $73.04 | 4 |
| Takeda Pharmaceuticals U.S.A., Inc. | $63.71 | 3 |
| Amneal Pharmaceuticals LLC | $28.42 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $28.34 | 1 |
| Adaptive Biotechnologies Corporation | $27.37 | 1 |
| GENZYME CORPORATION | $21.15 | 1 |
| PFIZER INC. | $20.00 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $20.00 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $19.82 | 1 |
| EMD Serono, Inc. | $19.65 | 1 |
| Pharmacosmos Therapeutics Inc. | $15.33 | 1 |
By program year
Records — PY2024 (66)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.